Corbus Pharmaceuticals Holdings, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 12.2M shares, a 175% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 12.2M +7.76M +175% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 11.5M +7.08M +160% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 10.5M +6.29M +149% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 4.42M +252K +6.05% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 4.42M -121M -96.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 4.42M -121M -96.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 4.22M -121M -96.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 4.17M +1.67K +0.04% Dec 31, 2022 10-K 2024-03-12
Q3 2022 125M +50K +0.04% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 125M +185K +0.15% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 125M +223K +0.18% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 4.17M -94.7M -95.8% Dec 31, 2021 10-K 2023-03-07
Q3 2021 125M +43M +52.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 125M +44.4M +55.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 125M +52.5M +72.5% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 98.9M +34.2M +52.9% Dec 31, 2020 10-K 2022-03-08
Q3 2020 82.2M +17.5M +27.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 80.7M +16M +24.8% Jun 30, 2020 10-Q/A 2020-08-31
Q1 2020 72.5M +8.04M +12.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 64.7M +7.43M +13% Dec 31, 2019 10-K 2021-03-15
Q3 2019 64.7M +7.44M +13% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 64.6M +7.45M +13% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 64.5M +7.32M +12.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 57.2M +1.64M +2.96% Dec 31, 2018 10-K 2020-03-16
Q3 2018 57.2M +7.01M +14% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 57.2M +6.97M +13.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 57.1M +7M +14% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 55.6M +10.9M +24.4% Dec 31, 2017 10-K 2019-03-12
Q3 2017 50.2M +6.24M +14.2% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 50.2M +6.47M +14.8% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 50.1M +12.5M +33.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 44.7M +7.08M +18.8% Dec 31, 2016 10-K 2018-03-12
Q3 2016 44M +6.38M +17% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 43.7M +13M +42.3% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 37.6M +11.6M +44.6% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 37.6M +11.7M +45% Dec 31, 2015 10-K 2018-03-12
Q3 2015 37.6M +11.8M +45.7% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 30.7M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 26M +65K +0.25% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 25.9M +19M +272% Dec 31, 2014 10-K 2016-03-28
Q3 2014 25.8M Sep 30, 2014 10-Q 2014-11-13
Q1 2014 25.9M Mar 31, 2014 10-Q 2015-05-13
Q4 2013 6.96M Dec 31, 2013 10-K 2015-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.